Search Results - "POON, Donald"
-
1
Multicenter phase II study of sequential radioembolization-sorafenib therapy for inoperable hepatocellular carcinoma
Published in PloS one (10-03-2014)“…The safety and tolerability of sequential radioembolization-sorafenib therapy is unknown. An open-label, single arm, investigator-initiated Phase II study…”
Get full text
Journal Article -
2
Analysis of Prognostic Factors of Comprehensive Geriatric Assessment and Development of a Clinical Scoring System in Elderly Asian Patients With Cancer
Published in Journal of clinical oncology (20-09-2011)“…To determine the impact of each comprehensive geriatric assessment (CGA) domain on overall survival (OS) and develop a prognostic scoring system for elderly…”
Get full text
Journal Article -
3
Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009
Published in The lancet oncology (01-11-2009)“…Summary Asia has a disproportionately large share of the world's hepatocellular carcinoma (HCC), mainly because of the endemic status of chronic hepatitis B…”
Get full text
Journal Article -
4
Dynamic contrast-enhanced CT imaging of hepatocellular carcinoma in cirrhosis: feasibility of a prolonged dual-phase imaging protocol with tracer kinetics modeling
Published in European radiology (01-05-2009)“…Dynamic contrast-enhanced (DCE) CT imaging of four patients with hepatocellular carcinoma (HCC) was performed using a dual-phase imaging protocol designed with…”
Get full text
Journal Article -
5
Identification of Comprehensive Geriatric Assessment Based Risk Factors for Malnutrition in Elderly Asian Cancer Patients
Published in PloS one (27-05-2016)“…Elderly cancer patients are at increased risk for malnutrition. We aim to identify comprehensive geriatric assessment (CGA) based clinical factors associated…”
Get full text
Journal Article -
6
Sorafenib and rapamycin induce growth suppression in mouse models of hepatocellular carcinoma
Published in Journal of cellular and molecular medicine (01-08-2009)“…Hepatocellular carcinoma (HCC) is the fifth most common malignancy worldwide. Vascular endothelial growth factor, platelet derived growth factor and the…”
Get full text
Journal Article -
7
AZD6244 enhances the anti-tumor activity of sorafenib in ectopic and orthotopic models of human hepatocellular carcinoma (HCC)
Published in Journal of hepatology (01-01-2010)“…Background & Aims Hepatocellular carcinoma (HCC) is a particularly vascularized solid tumor where the Raf/MEK/ERK pathway is activated; suggesting that…”
Get full text
Journal Article -
8
Activity of thalidomide and capecitabine in patients with advanced hepatocellular carcinoma
Published in American journal of clinical oncology (01-06-2012)“…Thalidomide has shown modest activity in advanced hepatocellular carcinomas (HCCs). Single-agent capecitabine has also been used in patients with HCC, with…”
Get full text
Journal Article -
9
Phase II trial of gemcitabine in combination with cisplatin in inoperable or advanced hepatocellular carcinoma
Published in Annals of the Academy of Medicine, Singapore (01-07-2008)“…Advanced hepatocellular carcinoma (HCC) has a dismal prognosis and is notoriously chemo-resistant. We conducted a Phase II prospective study to evaluate the…”
Get more information
Journal Article -
10
Gastrointestinal stromal tumour in the elderly
Published in Critical reviews in oncology/hematology (01-06-2009)“…Abstract Aim To analyze the outcome of elderly patients compared with the younger age group patients who were diagnosed with gastrointestinal stromal tumours…”
Get full text
Journal Article -
11
Stage 4 pancreatic adenocarcinoma harbouring an FGFR2-TACC2 fusion mutation with complete response to erdafitinib a pan-fibroblastic growth factor receptor inhibitor
Published in BMJ case reports (12-09-2021)“…We report a case of a frail 68-year-old woman with stage 4 pancreatic carcinoma harbouring a fibroblastic growth factor receptor 2 (FGFR2) fusion who achieved…”
Get full text
Journal Article -
12
Phase III study of pasireotide long-acting release in patients with metastatic neuroendocrine tumors and carcinoid symptoms refractory to available somatostatin analogues
Published in Drug design, development and therapy (01-01-2015)“…In a randomized, double-blind, Phase III study, we compared pasireotide long-acting release (pasireotide LAR) with octreotide long-acting repeatable…”
Get full text
Journal Article -
13
Molecular and Other Novel Advances in Treatment of Metastatic Epithelial and Medullary Thyroid Cancers
Published in Journal of oncology (2010)“…An understanding of the mutations of the proto-oncogenes and tumor suppressor genes that occur in thyroid cancers should eventually explain the diverse…”
Get full text
Journal Article -
14
RAD001 (everolimus) inhibits tumour growth in xenograft models of human hepatocellular carcinoma
Published in Journal of cellular and molecular medicine (01-07-2009)“…Hepatocellular carcinoma (HCC) is the fifth most common malignancy worldwide and highly resistant to available chemotherapies. Mammalian target of rapamycin…”
Get full text
Journal Article -
15
Abstract 6399: Real-world experience of an Asian pan-cancer combined DNA/RNA next generation sequencing (NGS) tissue biopsy assay
Published in Cancer research (Chicago, Ill.) (22-03-2024)“…Abstract Introduction: Comprehensive molecular profiling with combined DNA-RNA next-generation sequencing (NGS) on tumor tissue is now increasingly being used…”
Get full text
Journal Article -
16
Comprehensive Geriatric Assessment (CGA) based risk factors for increased caregiver burden among elderly Asian patients with cancer
Published in Journal of geriatric oncology (01-05-2016)“…Abstract Objective This study aims to identify Comprehensive Geriatric Assessment (CGA) based risk factors to help predict caregiver burden among elderly…”
Get full text
Journal Article -
17
Identification of comprehensive geriatric assessment based risk factors for malnutrition in elderly Asian patients with cancer
Published in Journal of clinical oncology (20-05-2013)“…Abstract only 9552 Background: Elderly patients with cancer are at increased risk for poor nutrition. Malnutrition is associated with increased morbidity and…”
Get full text
Journal Article -
18
The Influence of Primary Site on Outcomes in Leiomyosarcoma: A Review of Clinicopathologic Differences Between Uterine and Extrauterine Disease
Published in American journal of clinical oncology (01-08-2013)“…Leiomyosarcomas (LMS) comprise 25% of soft tissue sarcomas. Recent reports suggest differences in treatment outcomes between uterine (uLMS) and extrauterine…”
Get full text
Journal Article -
19
Triplet combination of gemcitabine, paclitaxel, and carboplatin followed by maintenance 5‐fluorouracil and folinic acid in patients with metastatic nasopharyngeal carcinoma
Published in Cancer (15-09-2008)“…BACKGROUND. Nasopharyngeal carcinoma (NPC) is a disease that is highly responsive to various chemotherapeutic agents. In the metastatic setting, 2‐drug…”
Get full text
Journal Article -
20
Quality of life of elderly patients undergoing concomitant chemoradiation therapy for head and neck cancers, including assessment of geriatric parameters
Published in Journal of clinical oncology (20-05-2012)“…Abstract only 6100 Background: Data on the quality of life of older patients undergoing concomitant chemoradiation therapy (CCRT) for head and neck (H&N)…”
Get full text
Journal Article